Oximic compounds as potential inhibitors of metacaspase-2 (TbMCA2) of Trypanosoma brucei
Biochemical and Biophysical Research Communications · 2024
DOI: 10.1016/j.bbrc.2024.150657 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Laura Helena Araujo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Center for Biochemical Research, University of Mogi das Cruzes, Av Dr. Cândido Xavier de Almeida e Souza, 200, 08780-991, Mogi das …. Hauptthemen laut MEDLINE: Trypanosoma brucei brucei, Molecular Docking Simulation, Caspases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Wellcome Trust, State of Sao Paulo Research Foundation.
Abstract (Originalsprache)
Metacaspases are a distinct class of cysteine proteases predominantly found in plants, fungi, and protozoa, crucial for regulating programmed cell death (PCD). They possess unique structural features and differ markedly from caspases in their activation mechanisms and substrate specificities, with a notable preference for binding basic residues in substrates. In this study, we introduced vanillin-derived oximic compounds to explore their pharmaceutical potential. We evaluated these compounds for their inhibitory effects on TbMCA2, a metacaspase in Trypanosoma brucei, identifying AO-7, AO-12, and EO-20 as promising inhibitors. AO-12 showed significant potential as a non-competitive inhibitor with notable IC50 values. Molecular docking studies were also conducted to evaluate the binding affinity of these compounds for TbMCA2. This research is particularly relevant given the urgent need for more effective and less toxic treatments for trypanosomiasis, a parasitic disease caused by trypanosomes. The absence of available vaccines and the limitations imposed by drug toxicity underscore the importance of these findings. Our study represents a significant advancement in developing therapeutic agents targeting metacaspases in trypanosomatids and highlights the necessity of understanding metacaspase regulation across various species. It provides valuable insights into inhibitor sensitivity and potential species-specific therapeutic strategies. In conclusion, this research opens promising avenues for novel therapeutic agents targeting metacaspases in trypanosomatids, addressing a critical gap in combating neglected diseases associated with these pathogens. Further research is essential to refine the efficacy and safety profiles of these compounds, aiming to deliver more accessible and effective therapeutic solutions to populations afflicted by these debilitating diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interdisciplinary Center for Biochemical Research, University of Mogi das Cruzes, Av Dr. Cândido Xavier de Almeida e Souza, 200, 08780-991, Mogi das Cruzes, Brazil.
- Pharmaceutical Science Department, Alfenas Federal University, Rua Gabriel Monteiro da Silva, 700, 37130-001, Alfenas, Brazil.
- Department of Biophysics, São Paulo Federal University, Rua Pedro de Toledo, 669, 7° floor, 04039-032, São Paulo, Brazil.
- Interdisciplinary Center for Biochemical Research, University of Mogi das Cruzes, Av Dr. Cândido Xavier de Almeida e Souza, 200, 08780-991, Mogi das Cruzes, Brazil. Electronic address: mauriciomachado@umc.br.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Wellcome Trust
- State of Sao Paulo Research Foundation
Zitieren
APA
Araujo, L. H., Bueno Chagas, T. A., Reis, T., de Morais Borba, J. R. B., Trujilho, M. N. R., Dalzoto, L. A. M., Marcondes, M. F., Juliano, M. A., Júdice, W. A. S., Veloso, M. P., & Machado, M. F. M. (2024). Oximic compounds as potential inhibitors of metacaspase-2 (TbMCA2) of Trypanosoma brucei. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150657
Vancouver
Araujo LH, Bueno Chagas TA, Reis T, de Morais Borba JRB, Trujilho MNR, Dalzoto LAM, et al. Oximic compounds as potential inhibitors of metacaspase-2 (TbMCA2) of Trypanosoma brucei. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150657
BibTeX
@article{Araujo2024,
author = {Araujo, Laura Helena and Bueno Chagas, Thaynan Aparecida and Reis, Taiz and de Morais Borba, João Ricardo Bueno and Trujilho, Mariana Nascimento Romero and Dalzoto, Laura de Azevedo Maffeis and Marcondes, Marcelo Ferreira and Juliano, Maria Aparecida and Júdice, Wagner Alves de Souza and Veloso, Márcia Paranho and Machado, Maurício Ferreira Marcondes},
title = {Oximic compounds as potential inhibitors of metacaspase-2 (TbMCA2) of Trypanosoma brucei},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
doi = {10.1016/j.bbrc.2024.150657}
}
EUVIMED